FCGRT and neoplasm: As diffusion is a main driver of tumor accumulation [27,28,29,30], a higher systemic availability of these radioimmunoconjugates, not being shuttled by the FcRn, could be the reason that they ended up with a more beneficial tumor-to-liver profile than those conjugated at 3:1.